Experimental Leishmania major infection in mice:: role of IL-10

被引:58
作者
Chatelain, R
Mauze, S
Coffman, RL
机构
[1] Univ Munich, Dept Dermatol, Lab Immunodermatol, D-80538 Munich, Germany
[2] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA
关键词
T helper subsets; Leishmania major infection; interleukin-10;
D O I
10.1046/j.1365-3024.1999.00224.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
L. major infection of mice induces polarized Th1 and Th2 responses that are correlated with healing of the infection (Th1) or a fatal disease (Th2). The Th subset specific cytokines, IFN gamma and IL-4, themselves were shown to be important factors for the differentiation into the;Th1 and Th2 pathways during infection. We studied the role of the Th2 cytokine IL-10 during leishmania infection: removal of endogenous IL-10 by anti-IL-10 treatment did not alter the Th2 cytokine pattern in non-healer mice nor did it modulate DTH reactivity, IgE production or fatal disease progression, bur partially blocked the IFN gamma inhibiting effect of rIL-4 in healer mice. During chronic infection similar amounts of IL-10 were produced in both healer and non-healer mice. However, at early time-points during infection IL-IO production was significantly higher in the non-healer;Th2 responder animals. IL-IO production in vitro caused significant inhibition of in vitro IFN gamma production. In conclusion IL-IO, unlike IL-4 and IFN gamma does not seem to play a readily detectable role in the Th subset differentiation during L. major infection. However, the high production of IL-IO early during infection in non-healer mice and inhibition of leishmania-specific IFN gamma production may contribute to drive the immune response cowards a: Th2 response.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 41 条
[1]  
ABRAMS JS, 1988, J IMMUNOL, V140, P131
[2]   STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES [J].
ABRAMS, JS ;
RONCAROLO, MG ;
YSSEL, H ;
ANDERSSON, U ;
GLEICH, GJ ;
SILVER, JE .
IMMUNOLOGICAL REVIEWS, 1992, 127 :5-24
[3]  
BELOSEVIC M, 1989, J IMMUNOL, V143, P266
[4]  
CARVALHO EM, 1994, J IMMUNOL, V152, P5949
[5]  
CHATELAIN R, 1992, J IMMUNOL, V148, P1182
[6]   2 TYPES OF MOUSE HELPER T-CELL CLONE .3. FURTHER DIFFERENCES IN LYMPHOKINE SYNTHESIS BETWEEN TH1 AND TH2 CLONES REVEALED BY RNA HYBRIDIZATION, FUNCTIONALLY MONOSPECIFIC BIOASSAYS, AND MONOCLONAL-ANTIBODIES [J].
CHERWINSKI, HM ;
SCHUMACHER, JH ;
BROWN, KD ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1229-1244
[7]   ROLE OF CYTOKINES IN THE DIFFERENTIATION OF CD4+ T-CELL SUBSETS INVIVO [J].
COFFMAN, RL ;
VARKILA, K ;
SCOTT, P ;
CHATELAIN, R .
IMMUNOLOGICAL REVIEWS, 1991, 123 :189-207
[8]  
COFFMAN RL, 1986, J IMMUNOL, V136, P949
[9]   LEISHMANIA-MAJOR INFECTION IN MICE - A MODEL SYSTEM FOR THE STUDY OF CD4+ T-CELL SUBSET DIFFERENTIATION [J].
COFFMAN, RL ;
CHATELAIN, R ;
LEAL, LMCC ;
VARKILA, K .
RESEARCH IN IMMUNOLOGY, 1991, 142 (01) :36-40
[10]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815